The goal of this study was to define the NGF and BDNF expression and secretion and their respective TrkA, TrkB and p75NTR receptors in DLBCL cells cultured under standard and apoptotic conditions, including exposure to rituximab, to evaluate a potential link between rituximab sensitivity and NT production. This evidence concerns the gene NTRK2 and diffuse large B-cell lymphoma.